Tom Miller is a scientist and entrepreneur with focus on the nexus of AI, chemistry, and biology. He joined the Caltech faculty in 2008 and was promoted to full professor in 2013. He’s published more than 130 peer-reviewed articles and patents and received numerous awards for research excellence. In 2020, Tom co-founded and became the CEO of Entos, a technology-driven biopharma that is disrupting the therapeutics landscape with its generative AI drug discovery platform. Entos has assembled a world-class team that unites pioneering AI experts and seasoned drug hunters with strong track records of success in delivering clinically validated breakthrough treatments. The Entos platform has been demonstrated to deliver high-quality, differentiated drugs to clinics with unprecedented speed and across multiple target classes and mechanisms of action. Entos is advancing an internal pipeline of clinical assets to address urgent unmet patent needs in oncology.